Skip to main content

LCD L38747: Peroral Endoscopic Myotomy (POEM)

LCD L38747, Peroral Endoscopic Myotomy (POEM), is the Local Coverage Determination that Palmetto GBA applies to claims from 7 states (AL, GA, NC, SC, TN, VA, WV), effective 2024-09-12 and first in force 2021-02-28. The policy text runs 637 words, and its billing and coding article A58287 lists 1 ICD-10-CM codes that support medical necessity for 1 procedure code. No other contractor publishes a policy with this title.

Compiled from CMS files by the QuickIntell RCM Editorial Team · Data effective · Method: reference methodology · Report a data correction

Data currency: Medicare Coverage Database LCD export: MCD release November 12, 2026 (effective November 8, 2026); Medicare Coverage Database billing and coding articles: MCD release November 12, 2026 (effective November 8, 2026). Next CMS release: weekly, every Thursday.

Contractor
Palmetto GBA
States and territories
7
AL GA NC SC TN VA WV
Revision effective
2024-09-12
Original effective
2021-02-28
Policy text
637 words
Covered ICD-10 codes (articles)
1

Where this LCD applies

Each contract number is a jurisdiction on the remittance; the policy binds claims processed under these contracts and no others.

Contracts that apply LCD L38747
ContractContractorTypeStates
11201Palmetto GBAA and B and HHH MACSC
11301Palmetto GBAA and B and HHH MACVA
11401Palmetto GBAA and B and HHH MACWV
11501Palmetto GBAA and B and HHH MACNC
11202Palmetto GBAA and B and HHH MACSC
11302Palmetto GBAA and B and HHH MACVA
11402Palmetto GBAA and B and HHH MACWV
11502Palmetto GBAA and B and HHH MACNC
10111Palmetto GBAA and B MACAL
10211Palmetto GBAA and B MACGA
10311Palmetto GBAA and B MACTN
10112Palmetto GBAA and B MACAL
10212Palmetto GBAA and B MACGA
10312Palmetto GBAA and B MACTN

Billing and coding article A58287: diagnoses and procedure codes

Since 2019 the codes live in the companion article rather than the LCD. Billing and Coding A58287 (Billing and Coding: Peroral Endoscopic Myotomy (POEM)) carries the diagnosis and procedure lists the contractor loads as the claims edit. CPT codes are shown as bare numbers because the descriptors are licensed by the AMA; HCPCS Level II descriptors are public and shown. Each article below opens its complete covered and non-covered ICD-10-CM lists, by group and with the contractor's group instructions, and the LCD code lookup answers whether one diagnosis is covered for one procedure code in a given state.

A58287: Billing and Coding: Peroral Endoscopic Myotomy (POEM) (Billing and Coding, effective 2022-01-01)

Covered ICD-10-CM codes
1
1 group
Non-covered ICD-10-CM codes
0
Procedure codes listed
1
Full article
cms.gov record
First 1 covered ICD-10-CM codes in A58287
ICD-10-CMDescription (FY2027)
K22.0Achalasia of cardia

Procedure codes: 43497.

Coverage indications, limitations and medical necessity

Achalasia is a disorder of the esophagus that makes it difficult for food and liquid to pass into the stomach. Achalasia results from the degeneration of ganglion cells in the myenteric plexus in the wall of the esophagus. This degeneration leads to failure of relaxation of the lower esophageal sphincter (LES) together with loss of peristalsis in the distal esophagus. The most common symptoms in patients with achalasia are dysphagia for solids and liquids as well as regurgitation of undigested foods or saliva. Additional symptoms include chest pain, heartburn, and difficulty belching. Complications of achalasia may include progressive dilation of the esophagus (megaesophagus) possibly leading to esophagectomy. Patients with achalasia are also at increased risk of developing esophageal cancer. Achalasia can be treated with pneumatic dilatation (PD), botulinum toxin injection, and surgical myotomy. Laparoscopic Heller Myotomy (LHM) is the most common surgical myotomy procedure for treatment of achalasia.

Peroral Endoscopic Myotomy (POEM) is the endoscopic complement of surgical myotomy and is a newer, less invasive procedure for the management of achalasia. POEM is an endoscopic procedure, which creates a tunnel in the submucosal layer of the esophagus and proximal stomach. Through this submucosal tunnel, an esophageal and gastric myotomy are made using a flexible endoscope. 1 The POEM procedure is performed in 4 steps: 1) mucosal incision/entry into the submucosa, 2) creation of a submucosal tunnel, 3) myotomy, and 4) closure of the mucosal incision. 6,7,8,12,21,23,24,31

POEM is a form of natural orifice transluminal endoscopic surgery (NOTES). The procedure is performed perorally, without any incisions in the chest or abdomen. The advantage of this approach is to reduce procedure-related pain and return patients to regular activities sooner than surgeries requiring external incisions.

POEM may be considered medically necessary for treatment of symptomatic, monometrically proven primary idiopathic achalasia, types I, II, or III. Prior to performing a POEM procedure, it is crucial to confirm that patients have the correct diagnosis of achalasia and the following documentation must be included in the clinician’s preoperative evaluation:

• History and physical exam – in cluding a standardized, validated symptom assessment form completed by all patients (i.e., Eckardt score ≥3);

• High-resolution esophageal manometry (HRM) – achalasia is subclassified according to the Chicago Classification of esophageal motility disorders, which is based upon the result of a high-resolution esophageal manometry test;

• Contrast esophagram – findings on contrast esophagram that are suggestive of achalasia include a narrowed esophagogastric junction (EGJ) with a "bird-beak" appearance and esophageal aperistalsis. Late or end-stage achalasia may give the appearance that the esophagus is significantly dilated, angulated, and tortuous, giving it a sigmoid shape 35 ;

• E sophagogastroduodenoscopy (EGD) – EGD sometimes reveals a dilated esophagus that contains residual material with normal appearing esophageal mucosa.

Contraindications — if 1 of the following conditions is present, the patient should not undergo POEM:

• Severe erosive esophagitis

• Significant coagulation disorders

• Liver cirrhosis with portal hypertension

• Severe pulmonary disease

• Esophageal malignancy

• Prior therapy that may compromise the integrity of the esophageal mucosa or lead to submucosal fibrosis, including recent esophageal surgery, radiation, endoscopic mucosal resection, or radiofrequency ablation

Previous therapies for achalasia, such as PD, botulinum toxin injection, or LHM, are not contraindications to POEM.

Prior to treatment with POEM, patients should be educated on the risk of gastroesophageal reflux disease (GERD). Also, follow-up acid suppression treatment should be considered after POEM. Patients should be counseled that treatments exist with a lower incidence of post-procedure GERD, such as LHM and PD.

POEM is considered a safe but complex procedure. POEM will be considered medically reasonable and necessary only if it is performed by adequately trained, experienced physicians in high-volume centers. These centers must have the available staff to address any potential adverse events from POEM immediately, including but not limited to gastrointestinal or cardio-thoracic complications.

Summary of evidence (opening)

POEM appears to be highly beneficial in the short-term management of achalasia. According to a 2014 (Stavropoulos, et al.) Natural Orifice Surgery Consortium for Assessment and Research (NOSCAR) POEM White Paper Committee, clinical success, defined as a post-treatment Eckardt score of ≤3 and/or a >50% decrease in the LES pressure, was achieved in 82% to 100% of patients. 22

Additional studies documented similar patient improvements after POEM using either a timed barium esophagram or quality of life (QOL) assessment:

Sharata, et al. (2015) reported on a consecutive patient cohort with clinical and objective outcomes. 21 Comprehensive data was collected prospectively on all subjects undergoing POEM from October 2010 to November 2013 at a single institution. Subjects were classified based on HRM results. Operative data and immediate outcomes were reviewed. Symptom scores, HRM, and timed barium swallow (TBS) were performed prior to the procedure. Subjects were asked to undergo routine postoperative testing 6-12 months following surgery with the addition of standard 24-hour pH to the preoperative protocol. Morbidity was defined as requiring additional procedures or prolonged hospital stay >2 days. 100 POEM patients were included in the final analysis. The mean age was 58 years (18-83 years). Results demonstrated that the primary presenting symptoms included dysphagia 81, chest pain 10, and regurgitation 9. The mean follow-up was 16 months. HRM diagnoses were 75 achalasia (30 type I, 43 type II, 2 type III), 12 nutcracker esophagus, 5 diffuse esophageal spasm (DES), and 8 isolated hypertensive non-relaxing LES. The mean operative time was 128 minutes. The median hospital length of stay (LOS) was 1 day. The overall morbidity was 6%; all these patients were treated endoscopically or with conservative management without further sequelae. The average LES resting/residual pressure significantly decreased (44.3/22.2 to 19.6/11.7 in millimeters of mercury). Esophageal emptying improved from 40% to 90% on TBS with 93% patients demonstrating >90% emptying at 1 minute. Of the achalasia patients, 36% (17/47) showed some return of normal peristalsis (≥70% peristalsis) on post-op HRM. Abnormal acid exposure was present on postoperative testing in 38% of patients (26/68). Of these, 14 patients were asymptomatic. No reflux patient required any additional antireflux procedure. Eckardt scores decreased from 6 to 1. Dysphagia was improved or eliminated in 97% of patients with a complete resolution accomplished in 89%. Complete dysphagia relief was better for achalasia patients (46/47 patients; 97.8%) vs. non-achalasia patients (17/24; 70.8%). Of those with preoperative chest pain, 91.5% reported complete relief. 4 patients have refractory dysphagia. 2 non-achalasia patients underwent subsequent LHM and 2 are improved following serial endoscopic dilatations. Sharata, et al. were able to conclude that despite reflux in 1 out of 3 of patients, POEM provides excellent relief of dysphagia (97%) and chest pain (91.5%) for patients with esophageal spastic disorders with acceptable procedural morbidity.

Teitelbaum, et al. (2013) looked at the effect on anatomic and functional outcomes regarding the differences in POEM vs. LHM since an antireflux procedure is not performed in POEM with mobilization of the hiatus. 26 This study looked at patients who underwent LHM or POEM and had both a pre- and postoperative timed barium esophagogram (TBE). TBEs were performed with 200 mL of contrast, with radiographs taken at 1, 2, and 5 minutes. Results demonstrated that a total of 17 LHM and 12 POEM patients had undergone pre- and postoperative TBEs. Both groups had decreased column heights postoperatively at 1, 2, and 5 minutes (LHM: pre, 15.6, 12.7, 11.3 cm vs. post, 3.6, 2.5, 1.8 cm; P

The contractor cites 36 sources in the bibliography; the full summary and analysis of evidence are in the CMS record.

Dates, lineage and related policies

Original determination effective
2021-02-28
Current revision effective
2024-09-12
Last reviewed by the contractor
2024-04-25
MCD version
9

Other related documents: A58561 (Response to Comments).

Using this policy on a claim

Match the documented indication to the covered indications above before the service is scheduled, carry a diagnosis from the article's covered list on the claim line (the diagnosis coverage checker tests one code pair against every article that applies in a state), and keep the elements the documentation section asks for in the record, because the contractor can request it later through medical review. A denial under this policy arrives as CARC 50 with remark N115; the LCD lookup guide walks through the appeal path and the Advance Beneficiary Notice rules, and the Palmetto GBA hub lists every other active policy from the same contractor.

For teams evaluating QuickIntell software

Where QuickIntell fits with this policy

If your team repeatedly reviews local coverage policies, explore QuickAuth for requirement checks, documentation and status tracking with staff oversight. Confirm the applicable policy, supported workflow and review responsibilities. Use QuickRCM to evaluate the separate claim and denial workflow.

Optional software evaluation, not payer support or help with an individual claim. For coverage or payment decisions, use the official sources on this page. Do not include patient information in a demo booking or inquiry.

Frequently asked questions

What does LCD L38747 cover?

Achalasia is a disorder of the esophagus that makes it difficult for food and liquid to pass into the stomach. Achalasia results from the degeneration of ganglion cells in the myenteric plexus in the wall of the esophagus. This degeneration leads to failure of relaxation of the lower esophageal sphincter (LES) together with loss of peristalsis in the distal esophagus. The most common symptoms in patients… The full 637-word policy text is reproduced below from the Medicare Coverage Database export of November 12, 2026.

Which states does LCD L38747 apply to?

Palmetto GBA applies it to Medicare claims in 7 states: AL, GA, NC, SC, TN, VA, WV. It binds only that contractor; outside these jurisdictions the same service is judged under the local contractor's own policy or, where none exists, claim by claim.

Which diagnosis codes support medical necessity under LCD L38747?

The companion billing and coding article A58287 lists 1 ICD-10-CM codes in 1 group that support medical necessity; the first 1 appear on this page, where the complete list opens by group with the contractor's group instructions.

How do I appeal a denial under LCD L38747?

A denial under LCD L38747 carries claim adjustment reason code 50 with remark code N115. Compare the documented indication with the policy's covered indications and article A58287's 1 covered diagnosis codes, then file a redetermination with Palmetto GBA within 120 days, record attached. If the service falls outside the policy, bill the patient only with a valid Advance Beneficiary Notice signed before the service.

Sources

Every figure on this page is taken from the CMS publications below, as released by the Centers for Medicare & Medicaid Services. Projection built 2026-11-16. Verify against the primary file before billing or contracting decisions. The reference methodology explains how each figure is computed from these files.

Disclaimer

The policy text and code lists are reproduced from the CMS Medicare Coverage Database export as an operational reference. Verify against the current LCD and article on cms.gov before billing; coverage depends on the full record and the contractor. Not legal, clinical or billing advice.

Found a figure that does not match the CMS file? Report a data correction with the CMS file and the value you expected; the request reaches the editorial team through the contact form.